查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1559590

Eubiotics的全球市场

Eubiotics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球Eubiotics市场将达到 100 亿美元

2023年全球Eubiotics市场预计为61亿美元，预计到2030年将达到100亿美元，2023年至2030年复合年增长率为6.3%。益生菌是本报告分析的细分市场之一，预计复合年增长率为 5.9%，到分析期结束时将达到 36 亿美元。预计未来八年有机酸领域的复合年增长率为 7%。

美国市场预计19亿美元，中国预计复合年增长率5.9%

到 2023 年，美国Eubiotics市场预计价值 19 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到17亿美元，2023年至2030年的分析期间复合年增长率为5.9%。其他值得注意的区域市场包括日本和加拿大，预计 2023 年至 2030 年将分别成长 5.8% 和 5.2%。在欧洲，德国的复合年增长率预计约为 5.2%。

2024 年新报告的特点

  • 完全访问影响者参与统计数据
  • 免费存取数位檔案和「MarketGlass」研究平台。我们独特的 MarketGlass 平台以整合和协作的方式汇集了世界各地专家的创造力和市场知识。我们最先进的工具提供世界一流的市场可视性，同时保护参与者的隐私和身分。本报告中提供的数字、统计数据和市场描述是基于该领域专家和影响者共用的经过充分审查的见解。
  • 使用即时资料模拟器工具和客製化报告功能参与互动式调查。
  • 客户全面连结同侪协作互动平台，实现企业间智慧交流
  • 1 年免费报告更新
  • 竞争覆盖范围，包括主要企业的全球市场占有率
  • 多个地区公司的市场影响分析（强/活跃/利基/次要）
  • 访问专家/影响者访谈、播客、新闻公告和活动主题演讲的 YouTube 视频

2024 年世界经济有何预期

货币紧缩以及由此带来的利率上升带来的地缘政治影响和经济不稳定预计将在2024年为全球经济带来动盪。一些因素将继续给復苏之路带来压力，包括中东的敌对行动和日益频繁的气候灾害。儘管存在风险，但一些积极因素正在显现，包括强劲的通货紧缩征兆、缓解对顽固通膨的担忧、供应链正常化以及儘管能源成本出现波动但价格仍趋缓。印度和美国等二十一国集团国家的选举可能会影响资本流动和投资策略。儘管印度作为全球投资目的地的地位日益突出，但在充满活力的人才和资本生态系统的推动下，美国科技公司将继续占据主导地位。对于寻求高成长潜力的投资者来说，硅谷和其他高科技公司的机会仍然具有吸引力，因为国内经济儘管放缓但仍具有弹性，且法规环境有利。欧洲持续应对紧缩的货币政策和景气衰退风险，但英国的前景最严峻，2024 年景气衰退的风险最高。中国仍然是通用凭证，其成长预计将受到政府支出和消费者支出改善的支持。动盪的环境可能为投资者和公司带来机会和挑战。将波动性视为成长的催化剂，并以敏捷性和策略远见来制定投资决策，对于生存仍然至关重要。

调查企业举例（共21家）

  • Bioproton Pty., Ltd.
  • Calpis Co., Ltd.
  • Cargill, Inc.
  • Dostofarm GmbH
  • DSM-Firmenich AG
  • Koninklijke DSM NV
  • MSPrebiotics, Inc.
  • NATURE'S TRUTH UK
  • Nuproxa Switzerland Ltd

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP11869

Global Eubiotics Market to Reach $10 Billion by 2030

The global market for Eubiotics estimated at US$6.1 Billion in the year 2023, is expected to reach US$10 Billion by 2030, growing at a CAGR of 6.3% over the period 2023-2030. Probiotics, one of the segments analyzed in the report, is expected to record 5.9% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Organic Acids segment is estimated at 7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 5.9% CAGR

The Eubiotics market in the U.S. is estimated at US$1.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 5.9% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 5.2% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 21 Featured) -

  • Bioproton Pty., Ltd.
  • Calpis Co., Ltd.
  • Cargill, Inc.
  • Dostofarm GmbH
  • DSM-Firmenich AG
  • Koninklijke DSM N.V.
  • MSPrebiotics, Inc.
  • NATURE'S TRUTH UK
  • Nuproxa Switzerland Ltd

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Eubiotics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Eubiotics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Eubiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Eubiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Eubiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Probiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Organic Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Organic Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Organic Acids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Phytogenics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Phytogenics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Phytogenics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Prebiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Solid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Solid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Solid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Nutrition & Gut Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Nutrition & Gut Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Nutrition & Gut Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Immunity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Yield by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Yield by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Yield by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Other Functions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Poultry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Poultry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Poultry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Swine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Swine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: World 16-Year Perspective for Swine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Ruminants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Ruminants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: World 16-Year Perspective for Ruminants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: USA 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: USA 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Canada 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Canada 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Japan 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Japan 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Japan 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 86: China Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: China 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: China 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: China 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: China 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Eubiotics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Eubiotics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for Eubiotics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Europe 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Europe 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 113: France Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: France 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: France 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 119: France Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: France 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: France 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Germany 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Germany 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Germany 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Germany 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Italy 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Italy 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Italy 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Italy 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 149: UK Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: UK 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: UK 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 155: UK Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: UK 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: UK 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Europe 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Europe 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Europe 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Europe 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Asia-Pacific 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Asia-Pacific 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Asia-Pacific 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Asia-Pacific 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of World 16-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of World Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of World Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of World 16-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of World Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of World Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of World 16-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of World Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of World Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of World 16-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION